All PlansCoverageMedium impact
Recall: Brimonidine
UPMC Health Plan·Ophthalmology, Optometry, Pharmacy·Pharmacy
Effective date
Mar 29, 2023
We identified it
Aug 7, 2026
Summary
Apotex Corp. is voluntarily recalling six lots of Brimonidine Tartrate Ophthalmic Solution, 0.15% due to cracked bottle caps that may compromise product integrity. This recall affects patients with open-angle glaucoma or ocular hypertension. Billing teams must identify affected patients and work with providers to ensure alternative medications are prescribed and billed appropriately.
Action Required
Immediately: Identify all patients currently prescribed Brimonidine Tartrate Ophthalmic Solution 0.15% from the recalled lots (obtain specific lot numbers from Apotex or the plan). Notify providers to switch affected patients to alternative IOP-reducing agents. Update billing records to reflect new medication codes for replacement prescriptions. Contact affected patients to inform them of the recall and coordinate transition to alternative therapy. Monitor claims submitted for recalled product and route to appropriate handling per plan guidelines. Pharmacy team should cross-reference patient records against recall lot numbers.